Amryt said the US Food and Drug Administration had given it  approval which will enable the opening of US clinical trials on their drug AP101.

Irish pharmaceutical company Amryt said on Monday that it had received IND (investigational new drug) approval from the US authorities that will allow(...)

Two members of the Manchester fire department in New Hampshire assess the condition of a man who had overdosed on heroin and who was revived with two doses of Narcan. Photograph: Don Emmert/AFP/Getty Images

In hindsight, it looks like a no-brainer. Take a tried and tested drug that addresses a burgeoning epidemic and make it easier to use. Then sit back a(...)

Amryt Pharma chief executive Joe Wiley.

Irish pharmaceutical company Amryt Pharma has won a designation for one of its key drugs which could make it eligible for a voucher ultimately worth u(...)

Preeclampsia is characterised by high blood pressure and signs of damage to other organs.

A Cork-based biotechnology company has secured €2 million in funding to develop a product to identify whether women could develop preeclampsia. Meta(...)

Ganoderma applanatum or artists’ conk mushrooms.

The medicinal use of mushrooms in Asian culture is widely known, but what is less known is that some of the most potent Asian medicinal mushrooms grow(...)

Richard Pops, chairman and chief executive officer of Alkermes. Photograph: Patrick Fallon/Bloomberg

Shares in Irish drug company Alkermes continued to slide as the company comes to terms with an FDA refusal to consider approval for a depression drug (...)

Mainstay Medical’s  ReActiv8 device for the treatment of chronic low back pain

Mainstay Medical has passed an “important milestone” on winning access to the key US market for its new implant therapy for people suffering from chro(...)

AventaMed co-founder John Vaughan, chairman Jack Cashman, co-founder and CEO Olive O’Driscoll and Bruce Clibborn of HBAN Boole Investment Syndicate. Photograph: Michael Mac Sweeney/Provision

AventaMed, a Cork-based medtech firm focused on simplifying surgical procedures, has secured a €1.8 million investment to enable the company to attain(...)

Greencore chief executive Patrick Coveney: the company said the recall was a “purely precautionary measure, as no finished products have been found to have listeria present and no confirmed illnesses have been reported”. Photograph: Cyril Byrne

Greencore shares fell by 7.2 per cent on Monday after it was forced to recall several product lines on foot of a listeria scare at its plant in Rhode (...)

Applegreen: closed at a 52-week high of €5.80 after announcing its first dividend payment to shareholders. Photograph: Cyril Byrne

Markets rallied on Tuesday as investors’ fears about the impact of Hurricane Irma and the nuclear stand-off with North Korea eased. DUBLIN Service s(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »